[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Letter to the Editor
July 2001

Continuing Treatment With Novel Antipsychotic Drugs Despite Leukopenia or Thrombocytopenia

Arch Gen Psychiatry. 2001;58(7):706-707. doi:10.1001/archpsyc.58.7.706

Novel antipsychotic medications are increasingly being used as first-line agents in treating schizophrenia as well as other psychotic disorders.1 Although olanzapine and quetiapine fumarate have not been reported to cause notable neutropenia, and blood monitoring is not required as is with clozapine, the following is a report of a case of persistent neutropenia in a patient treated with both agents.